Do Not Do Recommendation

 

Alirocumab is not recommended for treating primary non-familial hypercholesterolaemia or mixed dyslipidaemia in adults without a history of cardiovascular disease.

Do Not Do Recommendation Details

Recommendation:

Alirocumab is not recommended for treating primary non-familial hypercholesterolaemia or mixed dyslipidaemia in adults without a history of cardiovascular disease.

Interventions:
Alirocumab

Source guidance details

Guidance:
Alirocumab for treating primary hypercholesterolaemia and mixed dyslipidaemia (TA393)
Published date:
December 2016
Paragraph number:
1.1
Page number:
4

View all NICE do not do from this Guidance

There are no other recommendations for this guidance.